Plain-English translation of NCT07499440 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our PTSD research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether , a new medication containing two active ingredients, can safely and effectively help adults who have post-traumatic stress disorder (PTSD). Researchers will compare the medication to a placebo (a dummy pill with no active ingredients) to see if the treatment actually works. About 200 adults will participate across multiple sites in Australia and the United States.
PTSD can cause ongoing fear, anxiety, and distress that makes everyday life difficult. This trial exists to find out whether this new two-ingredient medication could offer a safe, effective treatment option for people struggling with trauma symptoms.
You likely qualify if…
You likely don't qualify if…
You would visit the research site multiple times over 12 weeks to receive either the new medication or a placebo pill—neither you nor the researchers would know which one you're getting. During your visits, the team will check your vital signs, ask questions about how you're feeling, and possibly do blood tests and heart monitoring. After your last dose, you'll come back one week later for a final safety check.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
Australia